Q-Centrix, the country’s leading clinical data management provider, has rapidly expanded its Research Network since its inception last year.
Established in 2023, the Q-Centrix Research Network is a member organization that provides hospitals with greater access to sponsored clinical research opportunities. It is comprised of and open to Q-Centrix hospital partners seeking to provide more research opportunities for their communities and industry partners focused on enabling access to clinical research.
HealthTech Insights: Recognizing Sleep as the Sixth Vital Sign: How Vivos Is Redefining Health Care
Working with over 1,200 hospitals and health systems, we quickly saw a gap in hospitals who wanted to bring clinical trials to their community and patients, and life sciences companies who historically have trouble finding the right patient population for their trials and studies.
Members include Bon Secours Mercy Health, Carle Health, Tampa General Hospital, John Muir Health, Renown Health, Onvida Health (formerly Yuma Regional Medical Center), Baptist Health Care, Summa Health, Tucson Medical Center, and Kootenai Health, representing 1,260,000+ patients across the communities they support.
In partnership with these hospitals, Q-Centrix has started supporting a range of pharmaceutical engagements, such as rapidly building fit-for-purpose data sets for retrospective studies and supporting hospitals with patient pre-screening for sponsored clinical trials.
HealthTech Insights: Acute Pain Models in Drug Development, Upcoming Webinar Hosted by Xtalks
The network’s growth illustrates hospitals’ and health systems’ desire to access more clinical trial opportunities for their communities and establish clinical trials as a standard of care.
“Working with over 1,200 hospitals and health systems, we quickly saw a gap in hospitals who wanted to bring clinical trials to their community and patients, and life sciences companies who historically have trouble finding the right patient population for their trials and studies,” said Victor Wang, SVP of Data & Research at Q-Centrix. “In fact, 2/3 of all clinical trials fail to enroll enough patients for an effective study.” Wang continues, “This is especially critical given the lack of diversity in so many of today’s clinical trials due to recruitment limitations.”
The Q-Centrix Research Network members include hospitals located across the country, from a 48-hospital system to individual facilities, including those with underserved patient populations who may rarely get the chance to participate in clinical research.
HealthTech Insights: Texas A&M Health Adopts Genomic Decision Support for Clinical Care
In addition to bringing research studies to new communities, the connections made through the Q-Centrix Research Network can also help hospitals secure new funding sources and gain more value from their clinical data.
“We are just at the beginning of building the bridges between hospitals and research,” notes Wang. “The idea has always been there, but the infrastructure, or more precisely, a company with the experience to provide the infrastructure, has not.”
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prweb
